Quick Answer
Elevance Health, Inc. reported Cash and Equivalents of $9.49 billion for fiscal year 2025.
Elevance Health, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $9.49B | +14.5% |
| 2024 | $8.29B | +27.0% |
| 2023 | $6.53B | -11.7% |
| 2022 | $7.39B | +51.4% |
| 2021 | $4.88B | -15.0% |
| 2020 | $5.74B | +16.3% |
| 2019 | $4.94B | +25.5% |
| 2018 | $3.93B | +9.0% |
| 2017 | $3.61B | -11.4% |
| 2016 | $4.08B | +92.9% |
| 2015 | $2.11B | -1.8% |
| 2014 | $2.15B | +36.0% |
| 2013 | $1.58B | -36.1% |
| 2012 | $2.48B | +12.4% |
| 2011 | $2.20B | +23.1% |
| 2010 | $1.79B | -62.9% |
| 2009 | $4.82B | +120.5% |
| 2008 | $2.18B | -21.1% |
| 2007 | $2.77B | +6.4% |
| 2006 | $2.60B | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.71B | +10.8% | +1.8% |
| June 30, 2025 | $8.56B | +31.8% | +14.1% |
| March 31, 2025 | $7.50B | +20.5% | -9.5% |
| December 31, 2024 | $8.29B | +27.0% | +5.4% |
| September 30, 2024 | $7.87B | -28.0% | +21.1% |
| June 30, 2024 | $6.50B | -35.0% | +4.4% |
| March 31, 2024 | $6.23B | -38.6% | -4.6% |
| December 31, 2023 | $6.53B | -11.7% | -40.2% |
- Elevance Health, Inc. showed an increase of +14.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2006–2025 period, Elevance Health, Inc.’s cash and equivalents has grown by 264.7% (from $2.60 billion to $9.49 billion).
- The most recent figure is from Elevance Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: